Table 1.

GnRH, GnRH Agonists’ Relative Potency, Route of Administration, and the Dose Regimen^2,51

	Relative Potency	Route of Administration	Dose Regimen
GnRH	1
Leuprolide (Lupron)	15	Subcutaneous injection	500-1000 mg/d
		Intranasal	400 mg _4 days
		Intramuscular depot	3.75-7.5 mg/month
			11.25 mg/3 months
Buserelin (Suprefact, CinnaFact)	20	Subcutaneous injection	200 mg/day
		Intranasal	300-344 mg × 4 days
Nafarelin (Synarel)		Intranasal	3 mg/month
		Intramuscular depot	depot 2-4 mg/month
Deslorelin (Ovuplant)	114
Histrelin (Vantas, Supprelin LA)	210	Subcutaneous injection	100 mg/day
Goserelin (Zoladex)		Subcutaneous implant	3.6 mg/month
			10.8 mg/3 months
Tryptorelin (Decapeptyl, Diphereline, Gonapeptyl, Trelstar)		Intramuscular depot	3 mg/month